Abbott lowers earnings forecast after $21B Exact Sciences buy
MedTech Dive • April 16, 2026
|
Boston Scientific plans $88.5M R&D expansion in Ireland
MedTech Dive • April 16, 2026
|
Medtronic confirms paclitaxel balloon’s efficacy in post-approval trial
MedTech Dive • April 16, 2026
|
Philips wins FDA nod for AI-powered, detector-based spectral CT tech - MassDevice
MassDevice • April 16, 2026
|
Rapid Medical earns FDA clearance for latest Tigertriever device - MassDevice
MassDevice • April 16, 2026
|
Latest News on MassDevice - MassDevice
MassDevice • April 17, 2026
|
Abbott cuts 2026 EPS guidance due to Exact Sciences dilution, posts Q1 sales beat - MassDevice
MassDevice • April 16, 2026
|
Aneuvo wins FDA clearance for spinal cord stim for neurorehabilitation - MassDevice
MassDevice • April 17, 2026
|
Zimmer Biomet wins expanded FDA nod for shoulder systems - MassDevice
MassDevice • April 16, 2026
|
Corify Care picks up FDA nod for cardiac mapping tech - MassDevice
MassDevice • April 17, 2026
|
Philips issues another correction for Trilogy Evo ventilators - MassDevice
MassDevice • April 16, 2026
|
GE HealthCare expands mammography collab with RadNet’s DeepHealth - MassDevice
MassDevice • April 17, 2026
|
Roivant’s CEO thinks China is a ‘red herring’
Fierce Biotech • April 16, 2026
|
A new benchmark for biotech IPOs? Kailera raises $625M to fund obesity pipeline
Fierce Biotech • April 17, 2026
|
Small pools, big ideas: How the rare disease community is reimagining clinical trials
Fierce Biotech • April 16, 2026
|
RyghtAI launches clinical site search engine to aid drug developers, CROs with trial design
Fierce Biotech • April 16, 2026
|
'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
Fierce Biotech • April 16, 2026
|
Johnson & Johnson hands back failed eye disease gene therapy to MeiraGTx
Fierce Biotech • April 16, 2026
|
Pfizer–backed Storm blows into $56M series C, launches phase 2 sarcoma trial
Fierce Biotech • April 16, 2026
|
Aligos sells China rights to HBV drug to hepatology player Amoytop in $445M deal
Fierce Biotech • April 16, 2026
|
Qiagen launches latest diagnostic for bloodstream infections
Fierce Biotech • April 16, 2026
|
Medical devices win 2026 Edison Awards for innovation
Medical Design & Outsourcing • April 17, 2026
|
Microstructure makes ePTFE a versatile medtech material
Medical Design & Outsourcing • April 16, 2026
|